Resume-aware faculty matching

Find professors who actually fit you

Upload your resume. Four AI agents analyze your background, rank the faculty who fit, inspect their recent research, and help you draft outreach — grounded in their actual work, not templates.

Free to startNo credit cardCancel anytime
Top matches Balanced preset
Dr. Sarah Chen
Stanford · Interpretability · NLP
91
Dr. Marcus Holloway
MIT · Robotics · RL
84
Dr. Aisha Okonkwo
CMU · Fairness · HCI
82
Nova · Professor Researcher · re-ranking top 20…
Jeff Yoder

Jeff Yoder

Verified

North Carolina State University · Molecular Biomedical Sciences

Active 1991–2026

h-index54
Citations15.6k
Papers16737 last 5y
Funding$1.3M
See your match with Jeff Yoder — sign in to PhdFit.Sign in

About

Sarah Ho is the CVM Director of Student Engagement at the College of Veterinary Medicine at NC State University. Her role involves fostering student development and engagement within the college community. The page highlights her contact information and her position as a key figure in student involvement, but does not provide specific details about her research focus, background, or key contributions.

Research topics

  • Biology
  • Cancer research
  • Immunology
  • Cell biology
  • Medicine
  • Evolutionary biology
  • Genetics
  • Pharmacology
  • Pathology

Selected publications

  • CliMA/ClimaAtmos.jl: v0.33.2

    Zenodo (CERN European Organization for Nuclear Research) · 2026-01-17

    otherOpen access

    ClimaAtmos v0.33.2 Diff since v0.33.1 📢 API Changes: 🚀 Features 📑 Documentation 🐛 Fixes

  • CliMA/ClimaAtmos.jl: v0.34.0

    Zenodo (CERN European Organization for Nuclear Research) · 2026-01-21

    otherOpen access

    ClimaAtmos v0.34.0 Diff since v0.33.2 Breaking changes Use SurfaceFluxes v0.15 📢 API Changes: 🚀 Features 📑 Documentation Technical documentation of atmosphere model (#287) 🐛 Fixes

  • CliMA/ClimaAtmos.jl: v0.33.1

    Zenodo (CERN European Organization for Nuclear Research) · 2026-01-07

    otherOpen access

    ClimaAtmos v0.33.1 Diff since v0.33.0 📢 API Changes: 🚀 Features 📑 Documentation 🐛 Fixes

  • Immune insights and toxicity testing: an interview with Jeff Yoder

    Disease Models & Mechanisms · 2025-11-01

    articleOpen access1st authorCorresponding

    Jeff YoderJeff Yoder is a professor at North Carolina State University, USA, where he leads a research programme in comparative immunology. His lab employs zebrafish and cell culture models, along with transcriptomic, genomic, phylogenetic and biochemical strategies, to study the molecular and functional evolution of innate immune receptors across all vertebrate lineages. In 2014, he began developing the zebrafish as a model for immunotoxicology research and currently studies how exposure to environmental contaminants adversely impacts immune function. This includes the effects of some per- and poly-fluoroalkyl substances (PFAS), often referred to as ‘forever chemicals’, that are a source of increasing concern for human health.Jeff received his PhD in cell and developmental biology from Harvard University, USA, in 1998, working with Dr Tim Bestor on mammalian DNA methylation. As a postdoctoral fellow in Dr Gary Litman's lab at the University of South Florida, USA, Jeff shifted his research focus to comparative immunology, studying a complex family of genes encoding putative natural killer cell receptors in zebrafish. He became a faculty member at the University of South Florida before moving to North Carolina State University in 2004, where he has run a National Science Foundation- and National Institutes of Health-funded research programme for over 20 years. In 2024, Jeff was appointed Executive Director of the Genetics and Genomics Academy at North Carolina State University. The Academy works across the university to build and strengthen interdisciplinary research programmes, advance graduate training, expand genetics and genomics knowledge for all undergraduate students, and enhance state-wide outreach programmes. In this interview, we discuss fish immune systems, environmental toxicology and the impact that PFAS can have on the immune system. What made you decide to pursue a career in research?So, this goes back to high school and college for me. In high school I did well in my math and science classes but was also involved in theatre productions, both on stage and backstage, and making goofy videos with my friends at the local community television station (we volunteered to run the camera at school board meetings so we could sign out the equipment to make our videos). I honestly had a minute when I pondered the pros and cons of going to college for science or moving to Hollywood to become the next sitcom or movie star. As you might have guessed, I chose to go to college and majored in the brand-new field of biotechnology at Worcester Polytechnic Institute (WPI) in Massachusetts, USA. While in college, I didn't really have a solid plan of what would come next. I assumed that I would get a job as a lab technician. Thankfully, WPI has a significant research requirement to graduate, and I found a biophysics lab at the Worcester Foundation for Experimental Biology – which no longer exists – that would take me on for a summer research experience using fluorescence resonance energy transfer to measure the length of complementary oligonucleotides via melting curves. Since this lab was in driving distance of WPI, I convinced the lab to allow me to complete my senior thesis with them. I ended up working on cell membrane dynamics during fertilization. So, this is where I actually answer your question. A postdoc in this lab suggested that if I enjoyed research I should apply to graduate school. I initially thought there was no way I could afford to go to graduate school, but he reassured me that, in the biomedical sciences, many schools will pay you a stipend. This was amazing news to me, and I ended up applying to, I think, 11 different PhD programmes. I ended up at the Biological and Biomedical Sciences programme at Harvard Medical School with a degree in cell and developmental biology. It was really in graduate school when I realized how much I enjoyed the scientific process and discovery and that I wanted to keep doing research as long as I could get paid to do it!Your lab uses zebrafish both to research the immune system and in toxicology studies. What makes zebrafish a good model to address questions in these areas?Zebrafish larvae are a strong vertebrate model for developmental toxicology because fertilization is external, providing researchers with the ability to observe embryonic development starting from the one-cell stage. This is complemented by their rapid development that results in a beating heart and circulation within 24 h. Then, you add in that the fish are transparent for several days, permitting in vivo observation of organ development. Finally, the larvae are small enough that you can place them in 96-well plates for imaging and functional or behavioural studies. These features, plus the fact that you can simply expose the zebrafish to chemicals by adding them into the water, really make zebrafish a superior whole-animal model for toxicology studies.Zebrafish larvae are also a strong model for studying innate immunity – specifically, neutrophil and macrophage function and behaviour. These haematopoietic cell lineages are fully functional in 3-day-old zebrafish larvae, and transgenic reporter lines have been developed that allow fluorescently tagged immune cells to be visualized in vivo in real time. Plus, I like the fact that the cells of the adaptive immune system (B and T cells) are not fully functional until the zebrafish are a few weeks old, giving us a developmental window in which we can study how the cells of the innate immune system function without the complexity of the adaptive immune system.What can we learn about the immune system from studying immune evolution in fish?We can learn a lot by studying immune gene evolution in fish. As jawed vertebrates, fish possess both an innate and an adaptive immune response and can be very useful for studying the basics of immune cell biology as well as the functional role of conserved immune genes. There are approximately 30,000 fish species on earth, which is about half of all vertebrates. Ray finned fish (Actinopterygii), which include over 96% of those 30,000 species (including zebrafish, catfish, and most of the non-shark and non-ray species), originated over 400 million years ago and, in that time, have come to occupy so many environmental niches that differ dramatically in salinity, temperature, oxygen levels and hydrostatic pressure. There are even fish that can live outside of water for extended periods of time, like lungfish and mudskippers. Thus, you can imagine the differences in the potential pathogens present in these different conditions. A lot of great work is going into studying how the genes of the immune system co-evolve with pathogen exposure, and one major thing that we've learned from studying the immune systems of fish is that there is such a wide range of strategies for fighting off pathogens. Fish encode far more Toll-like receptors than mammals, and we're just starting to identify their ligands. In addition, some fish lineages have lost significant parts of the immune system that we used to think were essential for vertebrate survival (Boehm, 2025). For example, Atlantic cod has lost MHC Class II genes but expanded their MHC Class I gene repertoire (Bjørnestad et al., 2024), while the sexual parasitism of some anglerfish species is correlated with the loss of a functional adaptive immune system (Swann et al., 2020). These are great examples to use when teaching comparative immunology. What we observe in humans and mice only represents the immune systems of 0.00003% of all vertebrates on the planet – the immunogenetic rules in humans and mice do not necessarily apply to other species. What this means is, if you want to use a fish to study human immunology, it is best to understand not only how their immune systems are similar, but also how their immune systems are different.…if you want to use a fish to study human immunology, it is best to understand not only how their immune systems are similar, but also how their immune systems are differentHaving established your lab in the field of comparative immunology, what encouraged you to work on environmental toxicology?I've been running a research program at North Carolina State University, or NC State, for over 20 years now, and my interest in immunotoxicology goes back to about 10 years ago. At that time, my research program was focused on identifying novel molecular mediators of innate immunity using the zebrafish model. Multiple research groups were developing new ways to use zebrafish larvae as a whole-animal model for innate immunity, studying aspects like chemotaxis and phagocytosis. My group was moving in that direction with antisense agents to knock down gene expression (this was before CRISPR). While I was doing my comparative immunology research, there was also a long-running program in environmental toxicology ongoing at NC State. And it just so happened that the toxicology faculty had invited leadership from the US National Institute of Environmental Health Sciences (NIEHS) and Environmental Protection Agency (EPA) to campus for a meet and greet. They were looking for synergies between the research at the university and the goals of the federal agencies – NC State is less than 20 miles from research labs for the EPA and NIEHS. Somehow, I was invited to attend, and I recall introducing myself by stating “I'm not a toxicologist, but an immunologist” and explaining that the functional assays we were developing for genetic screens using zebrafish larvae could be applied to chemical screens. Dr Dori Germolec, who was the Leader of the Systems Toxicology Group at NIEHS, had an interest in immunotoxicology, and this led to funding from the NIEHS to develop the zebrafish larvae as a model for environmental immunotoxicology (Phelps et al., 2020). My first graduate student who was fully invested in using zebrafish for immunotoxicology, Drake Phelps, was very interested in working on PFAS, so he really steered us in that direction.Please could you give a brief explanation of what PFAS are and why they pose a threat to human and environmental health?So PFAS is the abbreviation for per- and poly-fluoroalkyl substances, which are a large group of man-made and highly stable compounds, some of which have been around since the 1940s. PFAS possess very useful properties like resistance to heat, water and grease, and can be found in a range of consumer products and industrial applications, including non-stick cookware, stain-resistant furniture, waterproof clothing, fast food wrappers and firefighting foam (Glüge et al., 2020). The carbon-fluorine bonds in PFAS are highly stable and contribute to their heat resistance, which is important in products like cookware, but means that they are very persistent in the environment. PFAS are introduced into waterways, land and air through industrial waste and landfills and seem to be ubiquitous across the world. Further, many PFAS have been detected in the blood of people and animals all over the world and in certain food products we eat. Unfortunately, human exposures to certain PFAS have been linked to several adverse health outcomes, including increased risks for certain cancers, decreased immune function, and the disruption of body weight regulation and metabolism (DeWitt et al, 2025; Jass et al., 2025). As one might expect, as specific PFAS are identified as being harmful to humans and the environment, new replacement PFAS are being developed and synthesized, resulting in thousands of man-made PFAS on the planet.What have been the most important findings from your work on the impact of PFAS on the immune system?I think the finding that exposure to two specific PFAS, ammonium perfluoro(2-methyl-3-oxahexanoate) (GenX) and perfluorohexanoic acid (PFHxA), suppressed the respiratory burst (a key functional immune response) using both zebrafish larvae and a human neutrophil-like cell line has been the most important finding from my group so far (Phelps et al., 2023). We screened nine different PFAS that we knew were in the rivers of North Carolina and in North Carolina residents. I feel that there are two very important impacts from this study. First, we observed that the respiratory burst assay yielded basically the same result using zebrafish larvae and human cells, demonstrating that the zebrafish larvae can serve as a reliable model for assessing the effect of chemical exposures on this specific human immune response. Second, the results from our 4-day exposure study were so important for the people who had been exposed to these chemicals in their drinking water for decades. We are continuing these studies to investigate how these PFAS suppress immune function using omics-based approaches and have other ongoing studies examining how PFAS exposures impact other important immune functions.What do you think are currently the greatest challenges in understanding the effects of environmental chemicals?I think there are two major challenges. The first challenge is the vast number of chemicals in the environment. For example, the EPA has a database that lists nearly 15,000 different PFAS, with the majority having no toxicology data (Phelps et al., 2024; USEPA, 2025). The second challenge is remediation. This is especially true for PFAS, which, as I mentioned earlier, have extremely strong chemical bonds and have been dubbed ‘forever chemicals’. The stability of PFAS means they are persistent and accumulate in the environment, in plants and in animals – including people. It is estimated that over 99% of the people in the United States have detectable levels of PFAS in their blood. We can use filtration methods to remove PFAS from drinking water, but how do we get them out of the soil, oceans, air, animals and people?We can use filtration methods to remove PFAS from drinking water, but how do we get them out of the soil, oceans, air, animals and people?What key research question in your field are you most excited to see answered in the near future?I've been interested in natural killer (NK) cells in fish for a long time now. Newer data from single-cell transcriptome experiments really align with older cell-based studies that indicate that ray-finned fish possess NK cells. Although NK-like cell lines have been developed from the agriculturally important channel catfish (Shen et al., 2002; Yoder, 2004), there is currently no way to isolate this immune cell population from any fish. I am excited for new strategies that will allow us to identify, isolate and study the function of NK cells from ray-finned fish in vivo and in vitro – hopefully from zebrafish. It will be very exciting to see the commonalities between mammalian and fish NK cells, as well as to define the diverse cell surface receptors that mediate NK function.You have mentored many scientists throughout your career. What are some of the most important things to consider when mentoring junior researchers?I think that science communication is the most important skill for junior researchers to develop. This includes communicating with other scientists, through research talks, research papers and grant proposals, and then communicating with the public through outreach events. Being able to give a research seminar that does not get into experimental ‘weeds’ is an important skill to develop, especially when speaking to an audience with various scientific backgrounds. And being able to give talks that tell a ‘story’ at different levels can make someone a great communicator – emphasizing to the audience “why they should care” is so important.If you weren't a scientist, what career do you think you would have pursued?As I mentioned earlier, when I was in high school and college, I was involved with a number of theatre and local television productions and used to joke that my back-up career was as a game show host.Disease Models & Mechanisms (DMM) thanks Jeff Yoder for his willingness to be interviewed, and for sharing his unique experiences and perspectives with us. Jeff was interviewed by Katie Pickup, Reviews Editor for DMM, and this interview has been edited and condensed with the interviewee's approval.

  • Per- and polyfluoroalkyl substances alter innate immune function: evidence and data gaps

    Journal of Immunotoxicology · 2024-05-07 · 18 citations

    reviewOpen accessSenior authorCorresponding

    Per- and polyfluoroalkyl substances (PFASs) are a large class of compounds used in a variety of processes and consumer products. Their unique chemical properties make them ubiquitous and persistent environmental contaminants while also making them economically viable and socially convenient. To date, several reviews have been published to synthesize information regarding the immunotoxic effects of PFASs on the adaptive immune system. However, these reviews often do not include data on the impact of these compounds on innate immunity. Here, current literature is reviewed to identify and incorporate data regarding the effects of PFASs on innate immunity in humans, experimental models, and wildlife. Known mechanisms by which PFASs modulate innate immune function are also reviewed, including disruption of cell signaling, metabolism, and tissue-level effects. For PFASs where innate immune data are available, results are equivocal, raising additional questions about common mechanisms or pathways of toxicity, but highlighting that the innate immune system within several species can be perturbed by exposure to PFASs. Recommendations are provided for future research to inform hazard identification, risk assessment, and risk management practices for PFASs to protect the immune systems of exposed organisms as well as environmental health.

  • Investigating the Impact of Whole-Genome Duplication on Transposable Element Evolution in Teleost Fishes

    Genome Biology and Evolution · 2024-12-23 · 3 citations

    articleOpen access

    Transposable elements (TEs) can make up more than 50% of any given vertebrate's genome, with substantial variability in TE composition among lineages. TE variation is often linked to changes in gene regulation, genome size, and speciation. However, the role that genome duplication events have played in generating abrupt shifts in the composition of the mobilome over macroevolutionary timescales remains unclear. We investigated the degree to which the teleost genome duplication (TGD) shaped the diversification trajectory of the teleost mobilome. We integrate a new high coverage genome of Polypterus bichir with data from over 100 publicly available actinopterygian genomes to assess the macroevolutionary implications of genome duplication events on TE evolution in teleosts. Our results provide no evidence for a substantial shift in mobilome composition following the TGD event. Instead, the diversity of the teleost mobilome appears to have been shaped by a history of lineage-specific shifts in composition that are not correlated with commonly evoked drivers of diversification such as body size, water column usage, or latitude. Collectively, these results provide additional evidence for an emerging perspective that TGD did not catalyze bursts of diversification and innovation in the actinopterygian mobilome.

  • Human DOCK11 Deficiency Causes Defective Erythropoiesis and Systemic Inflammation

    Blood · 2023-11-02 · 1 citations

    article

    Erythropoiesis involves significant changes in the cells, which are mediated by the plasma membrane and the actin cytoskeleton. The composition of the actin cytoskeleton and the interaction between its components are dynamically modified during erythropoiesis, however the precise role that different actin regulators play during erythroid differentiation is poorly understood. The dedicator of cytokinesis (DOCK) family member DOCK11 regulates actin cytoskeleton dynamics via its guanine nucleotide exchange factor (GEF) activity, resulting in activation of the small Rho GTPase CDC42. CDC42 has been implicated in regulating the early stages of erythroid development, as well as the terminal maturation steps involving enucleation. However, the role of human DOCK11 in hematopoietic cell function and human disease had not been defined. We analyzed a cohort of four patients from four unrelated families presenting with recurrent infections, early-onset severe immune dysregulation, systemic inflammation, as well as normocytic anemia and anisocytosis of unknown origin. Using whole-exome sequencing, we identified rare, hemizygous germline mutations in DOCK11 in these patients. Two mutations - an early stop-gain mutation and a To study the role of DOCK11 during erythropoiesis, we generated a dock11-knockout zebrafish model. We found that the dock11-knockout zebrafish embryos recapitulated the anemia and aberrant erythrocyte morphology observed in human DOCK11 deficiency. The anemia was amenable to rescue with constitutively active CDC42, suggesting that DOCK11 regulates erythrocyte numbers in a CDC42-dependent manner. As a next step we modeled human erythroid differentiation in vitro using an erythroid liquid culture system starting from purified CD34+ cells. ShRNA-mediated knockdown of DOCK11 in CD34 + cells revealed impairment of cell growth and differentiation during erythroid development. In line with moderate erythroid hypoplasia observed in the bone marrow of one of the patients, these data suggest an erythroid-intrinsic role of DOCK11 during erythropoiesis. As the patients with germline DOCK11 defects also presented with recurrent infections and systemic inflammation, we further assessed the role of DOCK11 in immune cells. In line with its role in actin dynamics, we found that human DOCK11 regulates T-cell morphology and migration, suggesting that defects in DOCK11 might impact the T cells' capability to fight infections. We further uncovered that the immune dysregulation observed in the patients involved aberrant T-cell activation and cytokine production. Mechanistically, using cells from DOCK11-deficient patients and Dock11-knockout mice, we were able to show that Dock11 regulates cytokine production at the transcriptional level by modulating the nuclear translocation of the T-cell transcription factor NFATc1, known to regulate the production of several cytokines. Collectively, we identified germline loss-of-function mutations affecting the actin regulator DOCK11 in a previously unknown disorder associating anemia and systematic inflammation. This work earmarks the DOCK11-CDC42 axis as an attractive future target for the treatment of a broader range of immune and hematological diseases

  • Systemic Inflammation and Normocytic Anemia in DOCK11 Deficiency

    New England Journal of Medicine · 2023-06-21 · 32 citations

    articleOpen access

    Increasing evidence links genetic defects affecting actin-regulatory proteins to diseases with severe autoimmunity and autoinflammation, yet the underlying molecular mechanisms are poorly understood. Dedicator of cytokinesis 11 (DOCK11) activates the small Rho guanosine triphosphatase (GTPase) cell division cycle 42 (CDC42), a central regulator of actin cytoskeleton dynamics. The role of DOCK11 in human immune-cell function and disease remains unknown. We conducted genetic, immunologic, and molecular assays in four patients from four unrelated families who presented with infections, early-onset severe immune dysregulation, normocytic anemia of variable severity associated with anisopoikilocytosis, and developmental delay. Functional assays were performed in patient-derived cells, as well as in mouse and zebrafish models. We identified rare, X-linked germline mutations in DOCK11 in the patients, leading to a loss of protein expression in two patients and impaired CDC42 activation in all four patients. Patient-derived T cells did not form filopodia and showed abnormal migration. In addition, the patient-derived T cells, as well as the T cells from Dock11-knockout mice, showed overt activation and production of proinflammatory cytokines that were associated with an increased degree of nuclear translocation of nuclear factor of activated T cell 1 (NFATc1). Anemia and aberrant erythrocyte morphologic features were recapitulated in a newly generated dock11-knockout zebrafish model, and anemia was amenable to rescue on ectopic expression of constitutively active CDC42. Germline hemizygous loss-of-function mutations affecting the actin regulator DOCK11 were shown to cause a previously unknown inborn error of hematopoiesis and immunity characterized by severe immune dysregulation and systemic inflammation, recurrent infections, and anemia. (Funded by the European Research Council and others.)

  • Ancient Fish Lineages Illuminate Toll-Like Receptor Diversification in Early Vertebrate Evolution

    bioRxiv (Cold Spring Harbor Laboratory) · 2023-04-06 · 2 citations

    preprintOpen access

    Abstract Since its initial discovery over 50 years ago, understanding the evolution of the vertebrate adaptive immune response has been a major area of research focus for comparative geneticists. However, how the evolutionary novelty of an adaptive immune response impacted the diversity of receptors associated with the innate immune response has received considerably less attention until recently. Here we investigate the diversification of vertebrate Toll-like receptors (TLRs), one of the most ancient and well conserved innate immune receptor families found across the Tree of Life, integrating genomic data that represent all major vertebrate lineages with new transcriptomic data from Polypteriformes, the earliest diverging ray-finned fish lineage. Our analyses reveal TLR sequences that reflect the 6 major TLR subfamilies, TLR1, TLR3, TLR4, TLR5, TLR7, and TLR11, and also currently unnamed, yet phylogenetically distinct TLR clades. We additionally recover evidence for a pulse of gene gain coincident with the rise of the adaptive immune response in jawed vertebrates, followed by a period of rapid gene loss during the Cretaceous. These gene losses are primarily concentrated in marine teleost fish and synchronous with the mid Cretaceous anoxic event, a period of rapid extinction for marine species. Finally, we reveal a mismatch between phylogenetic placement and gene nomenclature for up to 50% of TLRs found in clades such as ray-finned fishes, cyclostomes, amphibians, and elasmobranchs. Collectively these results provide an unparalleled perspective of TLR diversity, and offer a ready framework for testing gene annotations in non-model species.

  • A chromosome-level genome assembly of longnose gar, <i>Lepisosteus osseus</i>

    G3 Genes Genomes Genetics · 2023-04-29 · 6 citations

    articleOpen access

    Holosteans (gars and bowfins) represent the sister lineage to teleost fishes, the latter being a clade that comprises over half of all living vertebrates and includes important models for comparative genomics and human health. A major distinction between the evolutionary history of teleosts and holosteans is that all teleosts experienced a genome duplication event in their early evolutionary history. As the teleost genome duplication occurred after teleosts diverged from holosteans, holosteans have been heralded as a means to bridge teleost models to other vertebrate genomes. However, only three species of holosteans have been genome-sequenced to date, and sequencing of more species is needed to fill sequence sampling gaps and provide a broader comparative basis for understanding holostean genome evolution. Here we report the first high quality reference genome assembly and annotation of the longnose gar (Lepisosteus osseus). Our final assembly consists of 22,709 scaffolds with a total length of 945 bp with contig N50 of 116.61 kb. Using BRAKER2, we annotated a total of 30,068 genes. Analysis of the repetitive regions of the genome reveals the genome to contain 29.12% transposable elements, and the longnose gar to be the only other known vertebrate outside of the spotted gar and bowfin to contain CR1, L2, Rex1, and Babar. These results highlight the potential utility of holostean genomes for understanding the evolution of vertebrate repetitive elements, and provide a critical reference for comparative genomic studies utilizing ray-finned fish models.

Recent grants

Frequent coauthors

  • Gary W. Litman

    University of South Florida St. Petersburg

    139 shared
  • Dustin J. Wcisel

    North Carolina State University

    39 shared
  • István Mikó

    University of New Hampshire

    36 shared
  • Patricia Mullins

    36 shared
  • James P. Balhoff

    36 shared
  • Andrew Deans

    Pennsylvania State University

    36 shared
  • Alex Dornburg

    University of North Carolina at Charlotte

    31 shared
  • Ronda T. Litman

    31 shared

Education

  • Ph.D., Cell and Developmental Biology

    Harvard University

    1997
  • B.S., Biology and Biotechnology

    Worcester Polytechnic Institute

    1990

Awards & honors

  • Sigma Xi Outstanding Senior Research Award
  • Resume-aware match score
  • Save to shortlist
  • AI-drafted outreach

See your match with Jeff Yoder

PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.

  • Free to start
  • No credit card
  • 30-second signup